AptarGroup, Inc. $ATR Stock Acquired by 180 Wealth Advisors LLC

Key Points

• 180 Wealth Advisors increased its AptarGroup stake by 149% in the third quarter, adding 12,104 shares to bring its holdings to 20,228 shares, valued at about $2.45 million. Institutional investors and hedge funds collectively own 88.52% of the stock.
• AptarGroup reported quarterly EPS of $1.52, beating the $1.47 estimate, while revenue rose 6% year over year to $1.02 billion. The company also raised its quarterly dividend from $0.48 to $0.50 per share.
• Analysts’ consensus rating is Moderate Buy, with an average price target of $164.14; five analysts rate the stock Buy and three rate it Hold.

180 Wealth Advisors LLC lifted its stake in AptarGroup, Inc. (NYSE:ATR - Free Report) by 149.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,228 shares of the industrial products company's stock after buying an additional 12,104 shares during the quarter. 180 Wealth Advisors LLC's holdings in AptarGroup were worth $2,451,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Geneos Wealth Management Inc. increased its holdings in shares of AptarGroup by 214.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company's stock valued at $25,000 after purchasing an additional 137 shares in the last quarter. Silvant Capital Management LLC purchased a new position in AptarGroup in the second quarter valued at $30,000. Parkside Financial Bank & Trust increased its holdings in AptarGroup by 41.9% in the second quarter. Parkside Financial Bank & Trust now owns 298 shares of the industrial products company's stock valued at $37,000 after buying an additional 88 shares in the last quarter. Global Retirement Partners LLC purchased a new position in AptarGroup in the second quarter valued at $46,000. Finally, Root Financial Partners LLC acquired a new position in shares of AptarGroup in the third quarter worth about $46,000. 88.52% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Shiela Vinczeller sold 765 shares of AptarGroup stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total transaction of $99,733.05. Following the transaction, the insider owned 26,313 shares in the company, valued at approximately $3,430,425.81. This trade represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Gael Touya sold 3,740 shares of the business's stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total value of $500,262.40. Following the transaction, the chief executive officer directly owned 29,102 shares in the company, valued at $3,892,683.52. This trade represents a 11.39% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.73% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ATR shares. Weiss Ratings reissued a "hold (c)" rating on shares of AptarGroup in a research note on Monday, September 21st. UBS Group started coverage on AptarGroup in a research note on Friday, October 9th. They issued a "neutral" rating and a $135.00 price target for the company. Deutsche Bank Aktiengesellschaft started coverage on AptarGroup in a research note on Wednesday, October 7th. They issued a "buy" rating and a $150.00 price target for the company. Raymond James Financial reaffirmed an "outperform" rating and issued a $160.00 price target on shares of AptarGroup in a report on Wednesday, July 15th. Finally, Bank of America reiterated a "buy" rating on shares of AptarGroup in a research report on Monday, November 2nd. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, AptarGroup currently has a consensus rating of "Moderate Buy" and an average price target of $164.14.

AptarGroup Trading Down 1.0%

Shares of AptarGroup stock opened at $142.61 on Friday. The company has a current ratio of 1.50, a quick ratio of 1.03 and a debt-to-equity ratio of 0.39. AptarGroup, Inc. has a twelve month low of $110.95 and a twelve month high of $148.63. The firm has a market capitalization of $9.04 billion, a PE ratio of 34.61, a P/E/G ratio of 4.16 and a beta of 0.33. The firm's 50-day moving average price is $126.84 and its 200 day moving average price is $127.49.

AptarGroup (NYSE:ATR - Get Free Report) last released its earnings results on Thursday, October 29th. The industrial products company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.05. AptarGroup had a return on equity of 13.11% and a net margin of 6.69%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $980.76 million. During the same quarter last year, the business posted $1.62 earnings per share. The business's quarterly revenue was up 6.0% compared to the same quarter last year. On average, sell-side analysts predict that AptarGroup, Inc. will post 5.54 EPS for the current fiscal year.

AptarGroup Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 12th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. This is a boost from AptarGroup's previous quarterly dividend of $0.48. The ex-dividend date is Thursday, November 12th. AptarGroup's dividend payout ratio (DPR) is currently 46.60%.

AptarGroup Company Profile

AptarGroup, Inc NYSE: ATR develops and manufactures dispensing, sealing and delivery systems for the pharmaceutical, beauty, personal care, food and beverage markets. Its products are designed to control, protect and dispense a wide range of liquids, creams, lotions, fragrances and other formulations.

The company's offerings include pumps, valves, closures, aerosol systems and other dispensing components, as well as drug-delivery technologies. Through its pharmaceutical business, Aptar supports nasal, pulmonary, ophthalmic, dermal and injectable applications, serving pharmaceutical and biotechnology companies with components and systems used in prescription, over-the-counter and consumer health products.

Aptar serves customers internationally through manufacturing, research and development and commercial operations across North America, Europe, Asia and other global markets.

Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup, Inc. (NYSE:ATR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.